Keiichiro Mori

Jikei University School of Medicine

Papers

5

Total Citations

87

H-Index

5

About

Dr. Keiichiro Mori is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted pelvic surgery, particularly for bladder and upper tract urothelial cancers. His major contributions include landmark meta-analyses clarifying the safety profile of the steep Trendelenburg position during robotic procedures—a critical concern for anesthesiologists and surgeons alike—and comparing intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy. These studies, cited over 60 times collectively, have helped standardize perioperative care and guide surgical technique selection. Dr. Mori also led the first multicenter external validation of the radical cystectomy pentafecta in a European cohort, establishing a benchmark for quality in robotic cystectomy with intracorporeal diversion. His work on distal ureter management during nephroureterectomy and temporal trends in urinary diversion reflects a sustained commitment to evidence-based practice. With publications spanning from 2021 to 2025, Dr. Mori’s research is shaping contemporary urologic oncology, offering clear, data-driven insights that directly impact patient safety and recovery.

Research Focus

Key Achievements

5
H-Index
5
Papers
87
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis
32 citations · 2021
📈 Most Prolific Year: 2021 (4 Papers)
🤝 Key Collaborators: 86
🏛 Institutions: Jikei University School of Medicine

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago